Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Eli Lilly Nears Deal for Cancer Biotech
05:20pm, Sunday, 19'th Apr 2026
Deal for Kelonia Therapeutics could come as soon as Monday.
2 Millionaire-Maker Stocks to Hold for the Next 10 Years
08:50am, Sunday, 19'th Apr 2026
These two companies have crushed broader equities over the long run. Both still have bright prospects, partly thanks to their work in AI.
These Alzheimer's drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated.
09:00am, Saturday, 18'th Apr 2026
A scientific report has raised questions about how much Leqimbi and Kisunla — the “breakthrough” Alzheimer's drugs that have hit the market in the last few years — really help slow the disease
Eli Lilly and Company $LLY Shares Acquired by Farther Finance Advisors LLC
07:14am, Saturday, 18'th Apr 2026
Farther Finance Advisors LLC lifted its stake in shares of Eli Lilly and Company (NYSE: LLY) by 30.8% during the fourth quarter, according to the company in its most recent disclosure with the Securit
Eli Lilly and Company $LLY Shares Acquired by Freestone Capital Holdings LLC
06:41am, Saturday, 18'th Apr 2026
Freestone Capital Holdings LLC lifted its stake in shares of Eli Lilly and Company (NYSE: LLY) by 5.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange C
Bingham Private Wealth LLC Acquires Shares of 1,002 Eli Lilly and Company $LLY
04:06am, Saturday, 18'th Apr 2026
Bingham Private Wealth LLC acquired a new stake in Eli Lilly and Company (NYSE: LLY) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 1,002 shares of the
Is This the Biggest Game-Changer in Lilly's 150-Year History?
03:00pm, Friday, 17'th Apr 2026
Eli Lilly could expand the weight loss market with its latest launch. The company should remain the leader in this niche.
Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake
12:04pm, Friday, 17'th Apr 2026
Reuters, citing IQVIA data, reported that Eli Lilly recorded 1,390 prescriptions for its newly launched obesity pill in the U.S. for the week ended April 10.
Lilly CEO sees weight-loss drugs reaching about half of potential users at peak
12:03pm, Friday, 17'th Apr 2026
Weight-loss drugs may eventually reach only about 50% of the overweight and obese people who could benefit from them due to complexities of healthcare systems and financial constraints, Eli Lilly C
Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied.
10:04am, Friday, 17'th Apr 2026
Eli Lilly's oral weight-loss drug, Foundayo, nabbed 1,390 prescriptions in its first week on the market, analysts said Friday.
Eli Lilly Weight-Loss Pill Prescriptions Near 1,400 in First Week
09:02am, Friday, 17'th Apr 2026
Eli Lilly (LLY, Financials) is off to a slow start with its new weight-loss drug. In its first week on the U.S. market, it only got roughly 1,390 prescriptions.
Financial Enhancement Group LLC Has $4.46 Million Stock Position in Eli Lilly and Company $LLY
05:10am, Friday, 17'th Apr 2026
Financial Enhancement Group LLC grew its stake in Eli Lilly and Company (NYSE: LLY) by 81.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Excha
887 Shares in Eli Lilly and Company $LLY Acquired by JM2 Capital Inc.
05:10am, Friday, 17'th Apr 2026
JM2 Capital Inc. purchased a new position in Eli Lilly and Company (NYSE: LLY) during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchase
Assetmark Inc. Purchases 3,523 Shares of Eli Lilly and Company $LLY
04:00am, Friday, 17'th Apr 2026
Assetmark Inc. raised its position in shares of Eli Lilly and Company (NYSE: LLY) by 6.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange
Lilly Reports 57% Lower Death Risk in Foundayo Cardiovascular Study
02:06pm, Thursday, 16'th Apr 2026
Eli Lilly and Co. (LLY) may be starting to regain some footing after recent regulatory scrutiny weighed on sentiment around its newly approved obesity pill, Found
